|
C-Type Lectin Domain Containing 10 A (CLEC10A)
|
Obesity, T2D
|
Adaptive and immune responses
|
|
Mitogen-Activated Protein Kinase 8 Interacting Protein 1 (MAPK8IP1)
|
T2D
|
Regulator of beta cell function and of immune function
|
|
Neuronal Growth Regulator 1 (NEGR1)
|
BMI, wait circumference, T2D
|
Cell adhesion
|
|
NAD(P)H Quinone Dehydrogenase 1 (NQO1)
|
Obesity, T2D. liver dysfunction
|
Anti-oxidant defences
|
|
Inhibin Subunit Beta E (INHBE )
|
Metabolic Syndrome, coronary heart disease
|
Cell proliferation, apoptosis, immune responses and hepatokine and hormone secretion
|
|
Glutamate receptor interacting protein 1 (GRIP1)
|
Metabolic syndrome (hepatic steatosis, hyperglycaemia and increased insulin resistance)
|
Macrophage and neuronal function and increased inflammation
|
|
Clusterin (CLU)
|
Glucose intolerance
|
Increased insulin resistance
|
|
Growth Factor Binding Protein 3 (IGFBP3)
|
Obesity, T2D, cerebrovascular disease
|
IGF binding protein affects vitamin D metabolism
|
|
Potassium Voltage-Gated Channel Subfamily Q Member 5 (KCNQ5)
|
Body mass index
|
Potassium channel
|
|
Cytotoxic And Regulatory T-Cell Molecule (CRTAM)
|
Body mass index and systolic hypertension
|
Innate immune system and determinant of insulin secretion
|
|
Spectrin (SPTA1)
|
HbA1c and T2D
|
Stability and structure of the cell membrane contributing to cell adhesion, cell spreading, and the cell cycle
|
